-
Percheron’s ATL1102 Program Featured in The Australian Newspaper
Read more: Percheron’s ATL1102 Program Featured in The Australian NewspaperAugust 7, 2024 In Australia, we have a long, proud history in healthcare and medical…
-
Interview with Chief Financial Officer & Company Secretary Ms Deborah Ambrosini
Read more: Interview with Chief Financial Officer & Company Secretary Ms Deborah AmbrosiniJuly 26, 2024
-
Interview with Chief Operating Officer Dr Anthony Filippis
Read more: Interview with Chief Operating Officer Dr Anthony FilippisJuly 24, 2024
-
Interview with Chief Medical Advisor Dr Cathryn Clary
Read more: Interview with Chief Medical Advisor Dr Cathryn ClaryJuly 22, 2024
-
Proactive Investors – Percheron continues to advance Duchenne treatment
Read more: Proactive Investors – Percheron continues to advance Duchenne treatmentMarch 6, 2024
-
Antisense Therapeutics Annual General Meeting 2023 Presentation
Read more: Antisense Therapeutics Annual General Meeting 2023 Presentation15 November 2023